Internal Medicine, Endocrinology, Diabetes, & Metabolism · Fullerton, CA
NPI
1942626767
Since 2014
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
4
Medicare group memberships
Hospitals
2
Hospital affiliations
100 E Valencia Mesa Dr Ste 105
Fullerton, CA, 92835
Phone (714) 446-5640
Groups this clinician bills Medicare through
Medicare paid, 2024
$59K
876 services
Medicare patients, 2024
224
Average age 71
Drug cost, 2024
$3.4M
7,847 prescriptions
Company payments, 2025
$1,876
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maximiliano Hyon was code 99214 (office e&m - established), 268 times for 128 patients. In total Maximiliano Hyon billed 876 services in 19 codes, and Medicare paid $59K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-01-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 268 | 128 | $102.63 | $28K |
| 83036 Blood Count | Office | 117 | 80 | $9.52 | $1,114 |
| 99232 Hospital E&M - Subsequent | Facility | 111 | 49 | $68.87 | $7,644 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 107 | 73 | $14.24 | $1,523 |
| 95251 Test - Miscellaneous | Office | 74 | 39 | $27.59 | $2,042 |
| 99222 Hospital E&M - Initial | Facility | 52 | 47 | $110.28 | $5,735 |
| 99204 Office E&M - New | Office | 37 | 37 | $133.26 | $4,931 |
| 99233 Hospital E&M - Subsequent | Facility | 30 | 20 | $103.71 | $3,111 |
By year: 2022 $55K for 780 services; 2023 $60K for 915 services; 2024 $59K for 876 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 117 | 80 | $9.52 | $1,114 |
Medicare prescription drug claims, 2024
In 2024, the drug Maximiliano Hyon prescribed most often to Medicare patients was Jardiance (Empagliflozin), with 687 prescriptions and refills. In total Maximiliano Hyon wrote 7,847 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Jardiance Empagliflozin | 687 | 1,186 | 186 | $659K |
| Ozempic Semaglutide | 676 | 925 | 137 | $837K |
| Metformin Hcl Generic | 546 | 1,420 | 183 | $4,329 |
| Atorvastatin Calcium Generic | 393 | 1,067 | 151 | $3,503 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 342 | 735 | 140 | $33K |
| Mounjaro Tirzepatide | 293 | 368 | 60 | $366K |
| Levothyroxine Sodium Generic | 244 | 671 | 79 | $3,434 |
| Kerendia Finerenone | 224 | 355 | 64 | $219K |
| Humulin 70/30 Kwikpen Insulin Nph Hum/Reg Insulin Hm | 210 | 312 | 48 | $31K |
| Humalog Kwikpen U-100 Insulin Lispro | 198 | 415 | 79 | $30K |
| Losartan Potassium Generic | 180 | 444 | 59 | $1,419 |
| Alendronate Sodium Generic | 178 | 452 | 58 | $1,279 |
| Metformin Hcl Er Metformin Hcl | 160 | 380 | 48 | $1,587 |
| Farxiga Dapagliflozin Propanediol | 144 | 285 | 40 | $151K |
| Tresiba Flextouch U-100 Insulin Degludec | 138 | 316 | 46 | $52K |
Brand drugs: 3,977 claims; generic drugs: 3,127 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maximiliano Hyon $1,876 ($1,876 in general payments such as food, travel and fees) from 21 companies. The largest payer was Novo Nordisk Inc with $244.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 11 | $244 |
| Amgen Inc. AMGN | 18 | $239 |
| Radius Health, Inc. | 21 | $183 |
| Ascendis Pharma Endocrinology Inc ASND | 16 | $183 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $170 |
| Corcept Therapeutics CORT | 13 | $169 |
| Recordati_rare_diseases_inc. | 7 | $160 |
| Abbott Laboratories ABT | 3 | $78.48 |
| Madrigal Pharmaceuticals MDGL | 2 | $70.24 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $62.45 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.